Stephen Schauer

1.0k total citations
7 papers, 261 citations indexed

About

Stephen Schauer is a scholar working on Physiology, Biological Psychiatry and Neurology. According to data from OpenAlex, Stephen Schauer has authored 7 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 2 papers in Biological Psychiatry and 2 papers in Neurology. Recurrent topics in Stephen Schauer's work include Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (2 papers) and Tryptophan and brain disorders (2 papers). Stephen Schauer is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (2 papers) and Tryptophan and brain disorders (2 papers). Stephen Schauer collaborates with scholars based in United States, Switzerland and Germany. Stephen Schauer's co-authors include Kristin R. Wildsmith, Lee Honigberg, W. Rodney Mathews, Surinder Kaur, David Arnott, Yuda Zhu, Joshua Haznedar, Ashley M. Smith, Stephen Salloway and Deborah L. Mortensen and has published in prestigious journals such as Drug Metabolism and Disposition, Alzheimer s & Dementia and Molecular Neurodegeneration.

In The Last Decade

Stephen Schauer

7 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Schauer United States	6	185	92	65	50	46	7	261
Kaleigh F. Roberts United States	7	214 1.2×	85 0.9×	53 0.8×	32 0.6×	55 1.2×	16	340
Yifan Dang China	9	181 1.0×	97 1.1×	38 0.6×	64 1.3×	56 1.2×	16	280
Nicola Voyle United Kingdom	9	276 1.5×	116 1.3×	102 1.6×	99 2.0×	54 1.2×	17	364
Tapan K. Khan United States	9	201 1.1×	156 1.7×	80 1.2×	98 2.0×	66 1.4×	12	429
Wesley Jongbloed Netherlands	10	261 1.4×	169 1.8×	85 1.3×	34 0.7×	57 1.2×	11	382
Eleni Gkanatsiou Sweden	11	258 1.4×	120 1.3×	78 1.2×	49 1.0×	69 1.5×	20	358
Maciej Dulewicz Poland	10	128 0.7×	106 1.2×	49 0.8×	23 0.5×	41 0.9×	34	280
Lisa M. Häsler Germany	6	185 1.0×	118 1.3×	27 0.4×	32 0.6×	60 1.3×	7	268
Paul T. Manser United States	9	186 1.0×	45 0.5×	103 1.6×	31 0.6×	36 0.8×	22	262
Dawn Matthews United States	7	96 0.5×	68 0.7×	33 0.5×	45 0.9×	33 0.7×	11	260

Countries citing papers authored by Stephen Schauer

Since Specialization

Citations

This map shows the geographic impact of Stephen Schauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Schauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Schauer more than expected).

Fields of papers citing papers by Stephen Schauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Schauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Schauer. The network helps show where Stephen Schauer may publish in the future.

Co-authorship network of co-authors of Stephen Schauer

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Schauer. A scholar is included among the top collaborators of Stephen Schauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Schauer. Stephen Schauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Schauer, Stephen, Balázs István Tóth, Julie Lee, et al.. (2024). Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology. Alzheimer s & Dementia. 20(12). 8855–8866. 7 indexed citations

Lee, Julie, Balázs István Tóth, Stephen Schauer, et al.. (2024). CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti‐tau antibody semorinemab. Alzheimer s & Dementia. 20(11). 7940–7953. 6 indexed citations

Schauer, Stephen, William Mylott, Moucun Yuan, et al.. (2018). Preanalytical approaches to improve recovery of amyloid-β peptides from CSF as measured by immunological or mass spectrometry-based assays. Alzheimer s Research & Therapy. 10(1). 118–118. 5 indexed citations

Salloway, Stephen, Lee Honigberg, Yong‐Yeon Cho, et al.. (2018). Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE). Alzheimer s Research & Therapy. 10(1). 96–96. 124 indexed citations

Liu, Peter, Julie Lee, Oskar Adolfsson, et al.. (2017). [P4–099]: CHANGES IN TAU PROTEIN LANDSCAPE DURING ALZHEIMER's DISEASE PROGRESSION. Alzheimer s & Dementia. 13(7S_Part_27). 2 indexed citations

Wildsmith, Kristin R., Stephen Schauer, Ashley M. Smith, et al.. (2014). Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics. Molecular Neurodegeneration. 9(1). 22–22. 100 indexed citations

Liu, Xingrong, Harvey Wong, Kimberly Scearce‐Levie, et al.. (2013). Mechanistic Pharmacokinetic-Pharmacodynamic Modeling of BACE1 Inhibition in Monkeys: Development of a Predictive Model for Amyloid Precursor Protein Processing. Drug Metabolism and Disposition. 41(7). 1319–1328. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact